Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)OCL 500 Treatment of Women With Symptomatic Uterine Fibroids
Not Applicable
Completed
- Conditions
- Uterine FibroidLeiomyomaMyoma
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- IMBiotechnologies Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT03427671
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
Not Applicable
Completed
- Conditions
- Benign Prostatic HyperplasiaBenign Prostatic Hypertrophy
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- IMBiotechnologies Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT02509975
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata
Not Applicable
Completed
- Conditions
- Leiomyomata
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- IMBiotechnologies Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT02410018
- Locations
- 🇺🇸
Albany Medical Center, Albany, New York, United States
News
No news found